Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 4.75p 4.50p 5.00p 4.75p 4.75p 4.75p 438 07:52:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 2.6 -0.5 -0.2 - 12.73

Byotrol Share Discussion Threads

Showing 6451 to 6474 of 6475 messages
Chat Pages: 259  258  257  256  255  254  253  252  251  250  249  248  Older
DateSubjectAuthorDiscuss
10/7/2017
12:51
And down we go again. No doubt this pile of poo will be sold off for the benefit of management and directors with the long suffering small shareholder picking up the bill. Same old same old
brownson
28/6/2017
17:13
Don't be so unwise as to think people only buy based on actual risk. A significant proportion of the spending decisions we make in our lives are based on all manner of illogical perceptions and beliefs.
milesy
28/6/2017
06:26
Maybe, but a slick sales force, alarmist headlines and fickle public can be used as leverage on these huge public chains and more-the market worldwide is enormous-to spend properly on infection control and cleanliness which, as we are all aware, is atrocious (do all these scruffy, transient and temporary waiters and baristas really comply as they should}. Byotrol has a tiny market cap-a smart ceo should be able to capitalize on what is an important and sensitive public health issue to grow it. imo http://www.bbc.co.uk/news/business-40426228
cumnor
27/6/2017
16:53
Unfortunately Byotrol seem to have the answer to which there is no problem
brownson
27/6/2017
16:25
Most are brownson thats true but apparently Byotrols is the exception with its 24hr protection being given EPA approval in the States. Pretty hot for a UK minnow imo. APPROVAL RECEIVED FROM U.S. ENVIRONMENTAL PROTECTION AGENCY ("EPA") FOR LONG-LASTING ANTI-MICROBIAL PRODUCT Byotrol plc, the specialist anti-microbial technology company, is pleased to announce that the US EPA has formally approved Byotrol's proprietary 24-hour germ-kill surface sanitizer for sale in the US (EPA Reg. Number 83614-1). The formulation has been under development at Byotrol for over seven years and the Directors believe offers unique performance characteristics to US consumers and businesses. To US consumers our products will be able to claim high performance cleaning and viricidal action, plus long-lasting benefits such as: -- 24-hour surface protection against bacteria -- Scientifically proven to kill >99.9% of bacteria for 24 hours -- 7 day mold and mildew prevention -- Eliminates >99.9% of viruses The Directors are not aware of any other cleaning or sanitizing products that can make such claims for US consumers; we believe this approval gives Byotrol a unique opportunity in the substantial US market.
bad gateway
18/6/2017
14:57
Wisecat, agree good to see shares rotating into new hands. Not an easy co to value due to the EPA approval, nvt someone with US distribution could pay a lot for this Whilst this is under the radar as regards investors I suspect that is not the case with the industry.
slicethepie
16/6/2017
16:45
Slicethepie determined seller yes but determined buyer as well over 10m shares traded this week late trades on Tuesday show 8.3m traded. Rocket ready....
wisecat2
14/6/2017
09:31
I see that finnCap raised their price target by 30% to 9p following yesterday's news
timbo003
13/6/2017
19:26
Seems to me like a pretty determined seller out there, very happy to have been able to buy more at these levels
slicethepie
13/6/2017
17:18
no reason to sell these - tree shaking following the big rise by market makers here - i bet. my guess is they are short of stock.
emeraldzebra
13/6/2017
11:39
Always been short of money for that sort of frippery ;¬) I thought the takeover back in March was a good deal too - always been about margin for me, and that was a very sensible move in the right direction. Excitement muted for that too, but should have a good long-term benefit. Taken together, the rocket should be well-justified given a little time.
supernumerary
13/6/2017
11:26
Quite a muted reaction It would almost certainly help if they actually employed a PR agency or arranged for an interview or two on VOX markets, Proactive, BRR media etc, if only to give shareholders and investors some sort of context. I will bring up their non-existent PR at the next AGM (although I mentioned it at the last one to no avail)
timbo003
13/6/2017
07:41
A unique, consumer meaningful claim (which presumably comes with a veritable fortress of IP protection) in the US is going to be worth many, many times the current market cap (circa £12m) to Consumer product behemoths such as Reckitts, Unilever etc
timbo003
13/6/2017
07:32
£70k? http://www.winchpharma.com/
maxk
13/6/2017
07:30
………;……̷0;……R30;
timbo003
13/6/2017
07:13
Wow!! Never thought they'd get that with US regs on cleaners so tough. Now they've got sole accesss to a $1b market. Might be a budding IDP here.
bad gateway
13/6/2017
07:09
Well done! This is a massive achievement for a uk company
slicethepie
24/3/2017
13:12
Blimey Mud...bet that cured the insomnia! I note it was for a PhD thesis, but didn't see if it was paid for/sponsored research?
milesy
23/3/2017
10:14
Some essential reading for Byotrollers. Https://www.escholar.manchester.ac.uk/api/datastream?publicationPid=uk-ac-man-scw:208902&datastreamId=FULL-TEXT.PDF
mudbath
13/3/2017
20:17
I am told by a friend who knew of the new Chairman John Langlands that he is some one who knows what he is doing. I bought in at 4.1p, so lets see. Anybody got any comments about the capital value of Byotrol at £10m.
paulbristol
13/3/2017
20:16
I am told by a friend who knew of the new Chairman John Langlands that he is some one who knows what he is doing. I bought in at 4.1p, so lets see. Anybody got any comments about the capital value of Byotrol at £10m.
paulbristol
13/3/2017
10:51
Bizarre really. Nathan Winch, CEO at WinchPharma commented, “I’d always been in touch with David; we had a good relationship from the start. They [Byotrol plc.] were instrumental in providing the technology required to make this project a reality… “
mudbath
13/3/2017
08:23
Well it's not retirement Nathan Winch only 27! Maybe BYOT were looking to end distribution deal to bring sales in house and came to a mutually beneficial settlement for the NHS licence? They control the supply so hold the cards.
cockerhoop
13/3/2017
07:54
Sorry bb2. http://www.winchpharma.com/brands-products/#gallery-details-475
maxk
Chat Pages: 259  258  257  256  255  254  253  252  251  250  249  248  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170724 08:52:27